Different antigenic distance metrics generate similar predictions of influenza vaccine response breadth despite moderate correlation
Jan 1, 2025·,
,,,,,,,,,·
0 min read
W. Zane Billings
Yang Ge
Amanda Skarlupka
Savannah L. Miller
Hayley Hemme
Murphy John
Natalie E. Dean
Sarah Cobey
Benjamin J. Cowling
Ye Shen
Ted M. Ross
Andreas Handel
Abstract
Introduction Influenza continuously evolves to escape population immunity, which makes formulating a vaccine challenging. Antigenic differences between vaccine strains and circulating strains can affect vaccine effectiveness (VE). Quantifying the antigenic difference between vaccine strains and circulating strains can aid interpretation of VE, and several antigenic distance metrics have been discussed in the literature. Here, we compare how the predicted breadth of vaccine-induced antibody response varies when different metrics are used to calculate antigenic distance. Methods We analyzed data from a seasonal influenza vaccine cohort which collected serum samples from 2013/14 – 2017/18 at three study sites. The data include pre– and post-vaccination HAI titers to the vaccine strains and a panel of heterologous strains. We used that data to calculate four different antigenic distance measures between assay strains and vaccine strains: difference in year of isolation (temporal), p -Epitope (sequence), Grantham’s distance (biophysical), and antigenic cartography distance (serological). We analyzed agreement between the four metrics using Spearman’s correlation and intraclass correlation. We then fit Bayesian generalized additive mixed-effects models to predict the effect of antigenic distance on post-vaccination titer after controlling for confounders and analyzed the pairwise difference in predictions between metrics. Results The four antigenic distance metrics had low or moderate correlation for influenza subtypes A(H1N1), B/Victoria, and B/Yamagata. A(H3N2) distances were highly correlated. We found that after accounting for pre-vaccination titer, study site, and repeated measurements across individuals, the predicted post-vaccination titers conditional on antigenic distance and subtype were nearly identical across antigenic distance metrics, with A(H1N1) showing the only notable deviation between metrics. Discussion Despite moderate correlation among metrics, we found that different antigenic distance metrics generated similar predictions about breadth of vaccine response. Costly titer assays for antigenic cartography may not be needed when simpler sequence-based metrics suffice for quantifying vaccine breadth.
Type
Publication
medRxiv

Authors
Amanda Skarlupka
(she/her)
Senior Program Manager at Vivli
I’m an infectious disease and data scientist advancing public health
through ethical, FAIR, and impactful data sharing. At Vivli, I lead
member engagement and strategic planning for the Antimicrobial
Resistance (AMR) Register and serve as a subject matter expert in data
governance and international data sharing. My work bridges researchers,
clinicians, and data scientists to drive innovation in health equity,
AI ethics, and open science.